Indivior is pioneering the development and discovery of treatment strategies for opioid use disorder.
Indivior’s R&D has led to a range of daily and monthly treatment options for patients with moderate-to -severe opioid use disorder.
To learn more about our commercially launched products, please visit the products page.
As part of its development and discovery process, Indivior is evaluating molecules and drug candidates that are too early stage to be listed below.
